18F-FDG kinetics in locally advanced breast cancer: correlation with tumor blood flow and changes in response to neoadjuvant chemotherapy

J Tseng, LK Dunnwald, EK Schubert… - Journal of Nuclear …, 2004 - Soc Nuclear Med
The aim of this study was to characterize the biologic response of locally advanced breast
cancer (LABC) to chemotherapy using 15O-water–derived blood flow measurements and …

Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy

DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2003 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant
chemotherapy followed by definitive surgery. The factors influencing the response of LABC …

Blood flow and metabolism in locally advanced breast cancer: relationship to response to therapy

DA Mankoff, LK Dunnwald, JR Gralow… - Journal of Nuclear …, 2002 - Soc Nuclear Med
Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant
chemotherapy followed by definitive surgery. The factors influencing the response of LABC …

18F-FDG PET–derived tumor blood flow changes after 1 cycle of neoadjuvant chemotherapy predicts outcome in triple-negative breast cancer

O Humbert, JM Riedinger, JM Vrigneaud… - Journal of Nuclear …, 2016 - Soc Nuclear Med
Previous studies have suggested that early changes in blood flow (BF) in response to
neoadjuvant chemotherapy and evaluated with 15O-water are a surrogate biomarker of …

Evaluation of breast tumor blood flow with dynamic first-pass 18F-FDG PET/CT: comparison with angiogenesis markers and prognostic factors

A Cochet, S Pigeonnat, B Khoury… - Journal of Nuclear …, 2012 - Soc Nuclear Med
The purpose of this study was to prospectively evaluate the relationship between tumor
blood flow and glucose metabolism as evaluated by dynamic first-pass 18F-FDG PET and …

Breast cancer blood flow and metabolism on dual-acquisition 18F-FDG PET: correlation with tumor phenotype and neoadjuvant chemotherapy response

O Humbert, M Lasserre, A Bertaut… - Journal of Nuclear …, 2018 - Soc Nuclear Med
Early changes in tumor glucose metabolism (SUVmax) and in tumor blood flow (BF) have
been evaluated separately for monitoring breast cancer response to neoadjuvant …

FDG metabolism and uptake versus blood flow in women with untreated primary breast cancers

KR Zasadny, M Tatsumi, RL Wahl - European journal of nuclear medicine …, 2003 - Springer
The aim of this study was to determine the relationship between tumor blood flow and
glucose utilization in women with untreated primary breast carcinomas. Noninvasive …

18F-FDG retention index and biologic prognostic parameters in breast cancer

AMG Vicente, ÁS Castrejón, FR Calatayud… - Clinical Nuclear …, 2012 - journals.lww.com
Aim: To analyze the correlation between [18 F]-fluoro-2-deoxy-D-glucose (18 F-FDG) uptake
assessed by positron emission tomography/computed tomography (PET/CT) in breast …

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis

N Avril, M Menzel, J Dose, M Schelling… - Journal of Nuclear …, 2001 - Soc Nuclear Med
Breast cancer is characterized by elevated glucose consumption resulting in increased
uptake of 18F-FDG. However, tracer uptake varies considerably among tumors imaged with …

Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography

R Bos, JJM Van der Hoeven, E Van der Wall… - Journal of Clinical …, 2002 - ascopubs.org
PURPOSE: Variable uptake of the glucose analog 18fluorodeoxyglucose (FDG) has been
noticed in positron emission tomography (PET) studies of breast cancer patients, with low …